论文部分内容阅读
麦迪霉素是大环内酯类抗生素,因其不易产生耐药性,对肝肾无明显损害,故易为众多病人接受。但诸多厂家产品的生物利用度及药
Midecamycin is a macrolide antibiotic, because it is not easy to produce resistance, no significant damage to the liver and kidney, it is easy for many patients to accept. However, many manufacturers of bioavailability and drug products